|Videos|July 27, 2021

Pharmaceutical CEO Leadership: Collaboration in Pharma – Innovation

In this segment, members of the Pharmaceutical CEO Leadership: Collaboration in Pharma panel talk about the need to think outside the box when it comes to partnering, for example, by expanding relationships with technology, data science, and logistics companies. The challenges of protecting intellectual property are also discussed, as are the effects innovation can have on pricing and access.

Read the full article "Capitalizing on Collaboration."


Related to this article

Former U.S. Representative Joe Cunningham (D-SC), spokesperson, Pharmaceutical Reform Alliance.
Former U.S. Representative Joe Cunningham (D-SC), spokesperson, Pharmaceutical Reform Alliance. dismisses the pharmaceutical industry's innovation argument against MFN pricing.
Joe Cunningham (D-SC) and spokesperson for the Pharmaceutical Reform Alliance,
Joe Cunningham argues that the most-favored-nation drug pricing agreements carry no legislative weight and discusses what the program actually locks in.